Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson’s Disease
Open Access
- 12 March 2010
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (3), 1082-1089
- https://doi.org/10.3390/ijms11031082
Abstract
Oxidized metabolites of dopamine known as dopamine quinone derivatives are thought to play a pivotal role in the degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease. Although such quinone derivatives are usually produced via the autoxidation of catecholamines, tyrosinase, which is a key enzyme in melanin biosynthesis via the production of DOPA and subsequent molecules, can potentially accelerate the induction of catecholamine quinone derivatives by its oxidase activity. We have developed neuronal cell lines in which the expression of human tyrosinase was inducible. Overexpression of tyrosinase resulted in increased intracellular dopamine content in association with the formation of melanin pigments in neuronal somata, which eventually causes apoptotic cell death. This cellular model will provide a useful tool for detailed analyses of the neurotoxicity of oxidized catechol metabolites.Keywords
This publication has 37 references indexed in Scilit:
- Parkin protects against tyrosinase‐mediated dopamine neurotoxicity by suppressing stress‐activated protein kinase pathwaysJournal of Neurochemistry, 2008
- Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolitesFEBS Letters, 2007
- Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelleJournal of Neural Transmission, 2006
- α‐Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's diseaseFEBS Letters, 2006
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Role of Quinones in ToxicologyChemical Research in Toxicology, 2000
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Tyrosinase: a comprehensive review of its mechanismBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Tyrosinase-like activity in normal human substantia nigraGeneral Pharmacology: The Vascular System, 1984
- Harding-Passey mouse-melanoma tyrosinase inactivation by reaction products and activation by l-epinephrineGeneral Pharmacology: The Vascular System, 1983